通过人工智能推进心血管风险评估:北卡罗来纳州的机遇和影响
Katherine M Conners1, Christy L Avery1, Faisal F Syed2
1Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
North Carolina medical journal
|June 28, 2024
概括
心血管疾病的死亡率正在上升,特别是在北卡罗来纳州. 人工智能 (AI) 可以分析心电图 (ECG) 来检测心脏加快衰老,改善风险评估和预防策略.
科学领域:
- 心脏病学 心脏病学
- 人工智能的人工智能
- 公共卫生 公共卫生
背景情况:
- 在北卡罗来纳州,心血管疾病 (CVD) 的死亡率正在增加.
- 心血管疾病死亡率的不平等仍然存在,跨种族,收入和地理位置.
- 电心电图 (ECG) 是广泛可用的,但在全面的心脏评估中未得到充分利用.
研究的目的:
- 探索人工智能 (AI) 在重新利用心电图数据以提高心脏功能障碍评估方面的潜力.
- 调查人工智能能够从心电图上识别加速心脏衰老的能力.
- 确定人工智能驱动的心电图分析是否可以为心血管疾病风险评估和预防提供新的见解.
主要方法:
- 使用人工智能算法来分析心电图 (ECG) 数据.
- 开发和验证人工智能模型,以检测指示加速心脏衰老的模式.
- 将人工智能识别的心脏衰老标记与现有的心血管风险因素和结果相关联.
主要成果:
- 人工智能成功地从标准心电图中识别了加速心脏衰老.
- 基于人工智能的心脏衰老评估显示了改善风险分层的潜力.
- 可能会揭示对心血管疾病差异背后的机制的新见解.
结论:
- 人工智能提供了一种有希望的,非侵入性的方法,可以通过使用ECG来提高心血管风险评估.
- 用人工智能驱动的对ECG加速心脏衰老的分析可以帮助解决心血管疾病死亡率的差异.
- 需要进一步的研究,以将AI-ECG分析纳入预防心血管疾病的临床实践.
更多相关视频
相关概念视频
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
136
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
136
Pre-Procedural Guidelines for Assessing Blood Pressure
544
Accurate blood pressure assessment is crucial for diagnosing and managing various health conditions. To ensure the reliability of these measurements, healthcare professionals must adhere to standardized pre-procedural guidelines. These guidelines enhance patient safety and improve the overall quality of healthcare. The following steps are essential for obtaining accurate and consistent blood pressure readings, from using the appropriate tools to ensuring effective communication with the...
544
Assessment of the Cardiovascular System I: Subjective Data
315
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
315
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
76
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
76


